PSYCHOTHERAPY FOR ADOLESCENTS, CHildren AND ADULTS
Here’s the latest on how there is a shift in psychiatry toward a new way of thinking about depression, its causes, and therapies.
The profession’s long embrace of the “monoamine hypothesis” — the idea that depression primarily results from abnormal levels of neurotransmitter chemicals in the brain and that drugs can restore the proper balance — is giving way to a more complex understanding and alternative treatments, from ketamine to psychedelics to magnetic stimulation.
Read moreIn a new “astromycological” venture launched in conjunction with NASA, mycologist Paul Stamets and various research teams are studying how fungi can be leveraged to build extraterrestrial habitats and perhaps someday even terraform planets.
Read moreThis study shows that many psychedelic users turn to storytelling to reframe challenging trips into positive experiences.
Read moreRecently, psychedelic drugs have once again taken popular culture by storm.
From the psychedelic startup companies newly forming on Wall Street to a recent New York Timesarticle that claims "psychedelic drugs are closer to medicinal use," it seems that there is a renewed media and medical interest in acid (LSD), mushrooms (psilocybin), ecstasy (MDMA), ayahuasca, DMT (dimethyltryptamine), and ketamine.
Read moreCheck out this podcast— Founder and Executive Director of the Multidisciplinary Association for Psychedelic Studies Rick Doblin discusses the role of MDMA-guided psychotherapy in treating PTSD.
Rick shares the story of how he developed a passion for healing the brain with psychedelics and the 35-year journey he’s endured to build a growing non-profit organization. He also explains how to effectively work with drugs that have been aggressively stigmatized and politicized.
Read moreAn unusual case report illuminates the therapeutic potential of psilocybin and neuroplasticity.
Read moreUpon the FDA approval of psychedelic medicine for psychiatric indications—such as MDMA for post-traumatic stress disorder or psilocybin for depression—psychiatric pharmacists in particular and all pharmacists generally, will play a pivotal role in the psychedelic medicine market in the US.
Read moreResearchers are looking at how to safely administer powerful psychedelics for treating depression and post-traumatic stress disorder.
Read moreMichael Pollan looks at the legalization of some psychedelics and asks how should we do drugs now?
Read morePsychedelic users say that even bad trips gave them ‘life-altering insights’, a small study finds.
Read morePsychedelics are promising treatments for mental illness. Dozens of new startups have sprung up to develop and deliver the drugs to patients in need.
Read more